South Korean dietary supplements manufacturers are accelerating their entries into the growing Chinese market as the number of elderly people continues to increase in the country, according to industry sources on Sunday. On the back of an aging population, the Chinese dietary supplements market grew 3 percent on-year to reach around 73 trillion won ($54.5 billion) in 2022, according to a report released by the Korea .
Unprecedented conditions have been created in the China-Belarus Industrial Park Great Stone for joint production of high-tech medical equipment and medicines.
China National Pharmaceutical Group, also known as Sinopharm, will step up efforts in innovation to propel high-quality development that is featured by further improvements in industrial, supply and value chains, according to senior company executives on Monday.